HSBC Holdings plc: Singapore Life sale in line with the Group’s strategic direction

Research evidence excerpt

HSBC Holdings plc: Singapore Life sale in line with the Group’s strategic direction

C A Z E N O V E Europe Equity Research

24 July 2026

HSBC Holdings plc Neutral

HSBA.L, HSBA LN

Singapore Life sale in line with the Group’s strategic Price (23 Jul 26):1,527p

direction Price Target (Dec-27):1,380p

HSBC announced the sale of 100% of HSBC Life Singapore to Allianz for US European Banks

AC$2.1bn, implying a valuation of c.1.55x HSBC Life Singapore’s FY25 Kian Abouhossein

comprehensive equity, worth up to 15bps CET1 upon completion in 1H27. The (44-20) 7134-4575

Group will also enter into a 15-year exclusive bancassurance agreement with kian.abouhossein@jpmorgan.com

Allianz post-transaction, allowing HSBC to continue offering insurance products J.P. Morgan Securities plc

to its retail and wealth management clients in Singapore and therefore we see a Sheel Shah, CFA

limited impact to client servicing. This transaction is in line with press reports (44-20) 7134-8455

sheel.shah@jpmorgan.com

earlier in the year (see here) and in line with the Group’s strategy to simplify its J.P. Morgan Securities plc

operations, with 13 exit transactions already announced over the past two years

Venkat Madasu

(including HSBC Life Singapore). HSBC Life Singapore has limited scale with a (44-20) 3493-9041

c6% market share and a market position outside of the top 4 in Singapore (trailing venkat.madasu@jpmorgan.com

Great Eastern, AIA, Prudential and Manulife) despite being the #1 insurer for J.P. Morgan Securities plc

HNW clients, and therefore this exit makes strategic sense, in our view, with capital Katherine Lei

likely to be diverted to other high-returning business areas with stronger market (852) 2800-8552

positions.